Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen; L. S. Gasbjerg; M. M. Rosenkilde; B. Hartmann; T. Vilsboll; J. J. Holst; M. B. Christensen; F. K. Knop

Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

S. Stensen, L. S. Gasbjerg, M. M. Rosenkilde, B. Hartmann, T. Vilsboll, J. J. Holst, M. B. Christensen, F. K. Knop

Original language	English
Publication date	Sept 2021
Publication status	Published - Sept 2021

Cite this

@conference{122f10befb1740a98060473540a5e39e,

title = "Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes",

author = "S. Stensen and Gasbjerg, {L. S.} and Rosenkilde, {M. M.} and B. Hartmann and T. Vilsboll and Holst, {J. J.} and Christensen, {M. B.} and Knop, {F. K.}",

year = "2021",

month = sep,

language = "English",

pages = "95--95",

}

TY - ABST

T1 - Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

AU - Stensen, S.

AU - Gasbjerg, L. S.

AU - Rosenkilde, M. M.

AU - Hartmann, B.

AU - Vilsboll, T.

AU - Holst, J. J.

AU - Christensen, M. B.

AU - Knop, F. K.

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract for conference

SP - 95

EP - 95

ER -